Argent Biopharma Ltd (ASX: RGT) Share Price and News

Price

$0.15

Movement

0.01 (-6.25%)

As at 24 Apr - Closed (20 mins delayed)

52 Week Range

$0.12 - $0.57

 
1 Year Return

-62.96%

Argent Biopharma Ltd Chart and Price Data

2025
2025
2025
2025
$0.00
$0.25
$0.50
$0.00
$0.25
$0.50
$0.00
$0.25
$0.50
$0.00
$0.25
$0.50

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $8.89 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 59.27 million
Earnings per share -0.407
Dividend per share N/A
Year To Date Return -11.76%
Earnings Yield N/A
Franking -
Earnings Yield

N/A

Franking

-

Dividend per share

N/A

Year To Date Return

-11.76%

Shares Outstanding

59.27 million

Earnings per share

-0.407

Share Price

$0.15

Day Change

0.01 (-6.25%)

52 Week Range

$0.12 - $0.57

Yesterday's Close

$0.16

Today's Open

$0.165

Days Range

$0.15 - $0.165

Volume

24,469

Avg. Volume (1 month)

48,040

Turnover

$3,816

As at 24 Apr - Closed

Argent Biopharma Ltd (ASX: RGT)
Latest News

Lab worker puts hands in the air and dances around
Healthcare Shares

The MGC Pharmaceuticals (ASX:MXC) share price soared 20% today. Here's why

The cannabis company's shares finished the week on a high note...

Read more »

A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
Healthcare Shares

MGC Pharmaceuticals (ASX:MXC) share price climbs on study approval

The Israeli Ministry of Health has approved a dosing study of a drug candidate. Here are the details

Read more »

A group of science or medical professionals cheering good news in the lab.
Healthcare Shares

Why the MGC Pharmaceuticals (ASX:MXC) share price is leaping 5%

MGC Pharma shares are talking the talk today after a key update. Here's what we know.

Read more »

Falling cannabis asx share price represented by cannabis leaves on a declining line graph
Share Market News

What's going wrong for ASX cannabis shares lately?

Why Aussie cannabis companies are worth watching right now...

Read more »

Cannabis from the earth in the hands
Share Gainers

MGC Pharma (ASX:MXC) share price jumps 11% on UK approval

This cannabis share is smoking the market today...

Read more »

A businessman leaps in the air outside a city building in the CBD.
Share Market News

MGC Pharmaceuticals (ASX:MXC) share price rockets 40% on supply deal

A new US supply and distribution deal has seen shares in the pharma company soar

Read more »

Three pills with faces showing sad to happy, indicating a rising share price for an ASX pharmaceutical company
Healthcare Shares

The MGC Pharmaceuticals (ASX:MXC) share price is on a roll today. Here's why

The MGC Pharmaceuticals (ASX: MXC) share price is up 3.4% after the company shared news of a $1 million order.

Read more »

A graphic showing a rising share price in medical cannabis shares
Share Gainers

Why the MGC Pharma (ASX:MXC) share price has rocketed 9%

The MGC Pharma Ltd (ASX: MGC) share price is rocketing higher amid a broader rebound and North American product update…

Read more »

The last piece of the jigsaw being fitted, indicating good news for a share price on merger or acquisition
Healthcare Shares

Why the MGC Pharmaceuticals (ASX:MXC) share price is up 5% today

The MGC Pharmaceuticals (ASX: MXC) share price is soaring with news the company will acquire a clinical research company.

Read more »

cannabis leaves on a rising line graph representing growth of ASX cannabis share price
Share Market News

Why the MGC Pharma (ASX:MXC) share price is zooming 13% higher today

The MGC Pharma (ASX: MXC) share price is up 13% in morning trade. We look at the latest from the…

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development
Share Market News

Why the MGC Pharmaceuticals (ASX:MXC) share price is jumping 8%

The MGC Pharmaceuticals (ASX:MXC) share price is surging after the company's drug was passed by two ethics committees. Here's the…

Read more »

medical asx share price represented by doctor giving thumbs up
Share Market News

Up 310% the MGC Pharma (ASX:MXC) share price is gaining again today

The MGC Pharma share price is gaining today, up 3% in late morning trade. We take a look at what's…

Read more »

RGT ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
24th Apr 2025 2025-04-24T11:40:38 s708A Cleansing NoticeYesNo11:40am1322k
24th Apr 2025 2025-04-24T11:35:43 Application for quotation of securities - RGTYesNo11:35am818k
24th Apr 2025 2025-04-24T11:34:28 Cancel - Application for quotation of securities - RGTYesNo11:34am818k
23rd Apr 2025 2025-04-23T18:51:19 s708A Cleansing NoticeYesNo6:51pm1324k
23rd Apr 2025 2025-04-23T18:46:09 Application for quotation of securities - RGTYesNo6:46pm818k
23rd Apr 2025 2025-04-23T18:44:19 Application for quotation of securities - RGTYesNo6:44pm819k
23rd Apr 2025 2025-04-23T18:41:29 Application for quotation of securities - RGTYesNo6:41pm818k
23rd Apr 2025 2025-04-23T18:41:29 Application for quotation of securities - RGTYesNo6:41pm818k
23rd Apr 2025 2025-04-23T18:37:53 Application for quotation of securities - RGTYesNo6:37pm818k
23rd Apr 2025 2025-04-23T18:36:18 Notification regarding unquoted securities - RGTYesNo6:36pm718k

About Argent Biopharma Ltd

MGC Pharmaceuticals Ltd. engages in the production of medical marijuana. Its Endocannabinoid system covers all cells and nerves; it is the messenger of information flowing between immune system and the central nervous system. The company was founded by Nativ Segev on October 21, 2005 and is headquartered in Perth, Australia.

RGT Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
24 Apr 2025 $0.15 $-0.01 -6.25% 24,469 $0.17 $0.17 $0.15
23 Apr 2025 $0.16 $-0.02 -11.11% 88,450 $0.20 $0.20 $0.16
22 Apr 2025 $0.18 $0.01 5.71% 9,189 $0.19 $0.19 $0.18
17 Apr 2025 $0.18 $0.00 0.00% 27,830 $0.18 $0.18 $0.18
15 Apr 2025 $0.18 $-0.01 -5.56% 38,512 $0.20 $0.20 $0.18
14 Apr 2025 $0.18 $0.00 0.00% 15,191 $0.18 $0.19 $0.18
11 Apr 2025 $0.18 $0.01 5.71% 578 $0.18 $0.18 $0.18
10 Apr 2025 $0.18 $-0.01 -5.41% 18,719 $0.19 $0.20 $0.18
09 Apr 2025 $0.19 $0.01 5.56% 39,387 $0.19 $0.22 $0.19
08 Apr 2025 $0.18 $-0.01 -5.26% 14,323 $0.19 $0.19 $0.18
07 Apr 2025 $0.19 $-0.01 -5.00% 31,828 $0.20 $0.20 $0.19
04 Apr 2025 $0.20 $0.01 5.13% 122,534 $0.20 $0.22 $0.16
03 Apr 2025 $0.20 $0.07 53.85% 498,844 $0.16 $0.27 $0.16
02 Apr 2025 $0.13 $-0.03 -18.75% 22,024 $0.17 $0.17 $0.13
01 Apr 2025 $0.16 $-0.01 -5.88% 11,900 $0.16 $0.16 $0.14
31 Mar 2025 $0.17 $0.01 6.25% 94 $0.16 $0.17 $0.16
28 Mar 2025 $0.16 $0.00 0.00% 1,308 $0.16 $0.16 $0.16

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
15 Oct 2024 Roby Zomer Buy 4,000,000 $1,640,000
As advised by the company.
10 Sep 2024 Roby Zomer Buy 1,258,500 $503,400
Off-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Daniel Robinson Non-Executive Director Dec 2023
Mr Robinson has been appointed as a Non-Executive Director of the Company effective immediately. Mr Robinson has over 20 years of experience in a broad range of corporate roles across stockbroking, corporate advisory, investor relations and governance. He is an experienced Company Secretary and Director of both private and listed companies. Additionally, Mr Robinson is a Member of the Australian Institute of Company Directors.
Mr Roby Reuven Zomer Chief Executive OfficerManaging Director Feb 2016
Mr Zomer is an executive with experience in the biopharmaceutical and biotech industries. As the CEO of the company, Roby has demonstrated has driven strategic growth, managed financial operations, and ensured compliance with industry-specific standards. He also served as the Chairman of the Board for Graft Polymer, overseeing the implementation of advanced polymer solutions in the Biotech, Automotive and Recycling sectors. Roby's entrepreneurial background includes founding and leading Green City Urban Recycling, a pioneering Israeli company focused on biofuel production. His innovative work in this field contributed to national energy independence initiatives and led to the company's acquisition by Rafael Advanced Defense Systems. With an industrial engineering and management foundation, Roby Zomer brings a blend of technical and strategic skills to his professional endeavors.
Mr Gary Hermon Non-Executive Director Mar 2025
Mr Hermon is a Company Director with over 30 years of experience in telecommunications, electrical systems, and infrastructure rollout. Throughout his career, he has managed projects for clients, including Hewlett-Packard, the Victorian Government, BP, and ExxonMobil. Previously, Mr Hermon founded Hercomm Cables & Security, where he managed nationwide rollouts for Hewlett-Packard and the Victorian Government. He also has experience overseeing electrical systems and communications for BP and ExxonMobil in Indonesia, India, and Papua New Guinea.
Mr Rowan Harland Company Secretary Mar 2023
-
Rowan Harland Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Oak Capital Partners Llc 8,370,718 17.29%
Group Capital Llc 3,913,812 8.09%
David Safren 3,405,016 7.03%
Citicorp Nominees Pty Limited 2,301,084 4.75%
Shlomie Bierman 2,230,874 4.61%
Computershare Clearing Pty Ltd <Ccnl Di A/C> 2,099,936 4.34%
Isamar Margareten 1,956,906 4.04%
Mr Shachar Shimony 1,933,000 3.99%
Yaakov Safren 1,643,802 3.40%
Jacob Goldstein 1,623,072 3.35%
Yoram Drucker 1,604,664 3.32%
Yosef Safren 1,565,526 3.23%
Shalom Safren 1,448,112 2.99%
Bioheka Limited 1,258,500 2.60%
Mrs Yifat Steuer 1,117,194 2.31%
Eliron Yaron 750,000 1.55%
A1 Invest Llc 625,000 1.29%
Mr Itay David Nissim 600,000 1.24%
Mr Amir Polak 592,626 1.22%
Joseph Schwartz 547,934 1.14%

Profile

since

Note